Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315972529> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2315972529 abstract "Background: Recent evidences have suggested that there are a rare population of cells called cancer stem cells (CSCs) in breast cancer, which have the ability of extensive self-renewal and contribute to metastasis and treatment resistance. This study evaluated the effects of an mTOR inhibitor, RAD001 (Everolimus) on breast CSCs of primary breast cancer cells and 2 breast cancer cell lines (MCF-7, MDA-MB-231) in vitro. Methods: Primarily, we isolated primary breast cancer cells from the 1cm 3 axenic tissue from breast cancer patients, which was been digested in collagenase typelV in 1-3 hours. After filtration, the cells from the organoid were plated in DMEM/F12(1:1) containing 10% FBS ,100U/ml penicillin,100µg/ml streptomycin and some growth factors overnight. The next day, we sorted CD44 +, CD24-/low, ESA + cells as breast CSCs by flow cytometry from primary breast cancer cells, breast cancer cell lines MCF-7 and MDA-MB-231. And then the three CSCs were treated with different concentrations of docetaxel alone(0,20µM,40µM,80µM, 160µM), mTOR inhibitor RAD001 alone (0,10nM,100nM,1µM,10µM), or in combination with docetaxel(20µM).the Inhibition of the drugs on different Breast CSCs was quantified by methyl thiazolyl tetrazolium (MTT) assay. All employed CSCs were divided into four groups, given respectively 24h treatment of RAD001(100nM), docetaxel(20µM), combination or contrals. Apoptosis and distribution of cell cycles were examined with flow cytometry. Experiments were performed in triplicate. Result: All three kinds of breast CSCs were resistant to the standard treatment doses of docetaxel in vitro(IC50=80 µM±5µM),compared with this drug inhibited normal breast cancer cell lines(IC50=16µM±2µM). Treatment with RAD001 resulted in growth inhibition of all employed CSCs in a dose-dependent manner, which is more effective than the treatment with docetaxel alone(P 20 =8nM).Combination studies showed that there was an additive growth inhibitory effect of a combination treatment on three CSCs in vitro compared with treatment with RAD001 alone (P 0.05). Discussion: We conclude that RAD001 has more effective inhibitory effect than docetaxel, and enhances the cytotoxic effects of docetaxel in models of breast CSCs in vitro by inducing cell cycle arrest, indicating that combination treatment with RAD001 and docetaxel may be an efficient therapy for refractory and metastatic breast cancer. But the drug interaction of RAD001 and docetaxel in the clinical situation has to be evaluated in further studies. Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr PD02-09." @default.
- W2315972529 created "2016-06-24" @default.
- W2315972529 creator A5005473353 @default.
- W2315972529 creator A5020313924 @default.
- W2315972529 creator A5030644488 @default.
- W2315972529 creator A5054043747 @default.
- W2315972529 creator A5064289060 @default.
- W2315972529 creator A5088930878 @default.
- W2315972529 date "2010-12-15" @default.
- W2315972529 modified "2023-09-27" @default.
- W2315972529 title "Abstract PD02-09: Effects of an mTOR Inhibitor RAD001 on Human Breast Cancer Stem Cells In Vitro" @default.
- W2315972529 doi "https://doi.org/10.1158/0008-5472.sabcs10-pd02-09" @default.
- W2315972529 hasPublicationYear "2010" @default.
- W2315972529 type Work @default.
- W2315972529 sameAs 2315972529 @default.
- W2315972529 citedByCount "0" @default.
- W2315972529 crossrefType "proceedings-article" @default.
- W2315972529 hasAuthorship W2315972529A5005473353 @default.
- W2315972529 hasAuthorship W2315972529A5020313924 @default.
- W2315972529 hasAuthorship W2315972529A5030644488 @default.
- W2315972529 hasAuthorship W2315972529A5054043747 @default.
- W2315972529 hasAuthorship W2315972529A5064289060 @default.
- W2315972529 hasAuthorship W2315972529A5088930878 @default.
- W2315972529 hasConcept C121608353 @default.
- W2315972529 hasConcept C126322002 @default.
- W2315972529 hasConcept C1491633281 @default.
- W2315972529 hasConcept C185592680 @default.
- W2315972529 hasConcept C190283241 @default.
- W2315972529 hasConcept C203014093 @default.
- W2315972529 hasConcept C2780932548 @default.
- W2315972529 hasConcept C2781190966 @default.
- W2315972529 hasConcept C28328180 @default.
- W2315972529 hasConcept C2908647359 @default.
- W2315972529 hasConcept C502942594 @default.
- W2315972529 hasConcept C530470458 @default.
- W2315972529 hasConcept C553184892 @default.
- W2315972529 hasConcept C55427017 @default.
- W2315972529 hasConcept C55493867 @default.
- W2315972529 hasConcept C71924100 @default.
- W2315972529 hasConcept C86554907 @default.
- W2315972529 hasConcept C86803240 @default.
- W2315972529 hasConcept C95444343 @default.
- W2315972529 hasConcept C96232424 @default.
- W2315972529 hasConcept C99454951 @default.
- W2315972529 hasConceptScore W2315972529C121608353 @default.
- W2315972529 hasConceptScore W2315972529C126322002 @default.
- W2315972529 hasConceptScore W2315972529C1491633281 @default.
- W2315972529 hasConceptScore W2315972529C185592680 @default.
- W2315972529 hasConceptScore W2315972529C190283241 @default.
- W2315972529 hasConceptScore W2315972529C203014093 @default.
- W2315972529 hasConceptScore W2315972529C2780932548 @default.
- W2315972529 hasConceptScore W2315972529C2781190966 @default.
- W2315972529 hasConceptScore W2315972529C28328180 @default.
- W2315972529 hasConceptScore W2315972529C2908647359 @default.
- W2315972529 hasConceptScore W2315972529C502942594 @default.
- W2315972529 hasConceptScore W2315972529C530470458 @default.
- W2315972529 hasConceptScore W2315972529C553184892 @default.
- W2315972529 hasConceptScore W2315972529C55427017 @default.
- W2315972529 hasConceptScore W2315972529C55493867 @default.
- W2315972529 hasConceptScore W2315972529C71924100 @default.
- W2315972529 hasConceptScore W2315972529C86554907 @default.
- W2315972529 hasConceptScore W2315972529C86803240 @default.
- W2315972529 hasConceptScore W2315972529C95444343 @default.
- W2315972529 hasConceptScore W2315972529C96232424 @default.
- W2315972529 hasConceptScore W2315972529C99454951 @default.
- W2315972529 hasLocation W23159725291 @default.
- W2315972529 hasOpenAccess W2315972529 @default.
- W2315972529 hasPrimaryLocation W23159725291 @default.
- W2315972529 hasRelatedWork W1559280824 @default.
- W2315972529 hasRelatedWork W1882528117 @default.
- W2315972529 hasRelatedWork W1986087165 @default.
- W2315972529 hasRelatedWork W2023448359 @default.
- W2315972529 hasRelatedWork W2255115823 @default.
- W2315972529 hasRelatedWork W2333695010 @default.
- W2315972529 hasRelatedWork W2350964657 @default.
- W2315972529 hasRelatedWork W2358383111 @default.
- W2315972529 hasRelatedWork W2362347883 @default.
- W2315972529 hasRelatedWork W2365398465 @default.
- W2315972529 hasRelatedWork W2369464613 @default.
- W2315972529 hasRelatedWork W2375754982 @default.
- W2315972529 hasRelatedWork W2377934031 @default.
- W2315972529 hasRelatedWork W2379967327 @default.
- W2315972529 hasRelatedWork W2381956610 @default.
- W2315972529 hasRelatedWork W2390656650 @default.
- W2315972529 hasRelatedWork W2585501848 @default.
- W2315972529 hasRelatedWork W2604567159 @default.
- W2315972529 hasRelatedWork W3107316156 @default.
- W2315972529 hasRelatedWork W2354239616 @default.
- W2315972529 isParatext "false" @default.
- W2315972529 isRetracted "false" @default.
- W2315972529 magId "2315972529" @default.
- W2315972529 workType "article" @default.